HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.

AuthorsBirgit C Schultes, L Mary Smith, Christopher F Nicodemus
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 13 Issue 13 Pg. 4026; author reply 4026-7 (Jul 01 2007) ISSN: 1078-0432 [Print] United States
PMID17606738 (Publication Type: Clinical Trial, Phase I, Letter, Comment)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • CA-125 Antigen
  • abagovomab
Topics
  • Animals
  • Antibodies, Anti-Idiotypic (therapeutic use)
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • CA-125 Antigen (chemistry)
  • Enzyme-Linked Immunosorbent Assay
  • Fallopian Tube Neoplasms (drug therapy, immunology)
  • Female
  • Humans
  • Immune System
  • Immunotherapy (methods)
  • Mice
  • Ovarian Neoplasms (drug therapy, immunology)
  • Peritoneal Neoplasms (drug therapy, immunology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: